NEW YORK, Jan. 8, 2012 /CNW/ - Emo Capital Corp (OTCBB:EMOE.OB)
announced today that it has obtained approval from the Financial
Industry Regulatory Authority (FINRA) to change its trading symbol from
"EMOE" to "NUVI" effective Monday January 9th, 2012.
The symbol change is another key step in the Company's strategy to
rebrand its corporate identity through its wholly owned subsidiary
NuVitality Labs. NuVitality Labs is a direct marketing corporation
specializing in health and wellness categories.
Statements in this press release may be "forward-looking statements"
within the meaning of the Private Securities Litigation Reform Act of
1995. Words such as "anticipate," "believe," "estimate," "expect,"
"intend", "dramatically" and similar expressions, as they relate to the
company or its management, identify forward-looking statements. These
statements are based on current expectations, estimates and projections
about the company's business based, in part, on assumptions made by
management. These statements are not guarantees of future performance
and involve risks, uncertainties and assumptions that are difficult to
predict. Therefore, actual outcomes and results may, and probably will,
differ materially from what is expressed or forecasted in such
forward-looking statements due to numerous factors, including those
described above and those risks discussed from time to time in Emo
Capital's filings with the Securities and Exchange Commission. In
addition, such statements could be affected by risks and uncertainties
related to the ability of the company to control product demand, market
and customer acceptance, competition, pricing and development
difficulties, as well as general industry and market conditions and
growth rates and general economic conditions. Any forward-looking
statements speak only as of the date on which they are made, and the
company does not undertake any obligation to update any forward-looking
statement to reflect events or circumstances after the date of this
release. Information on Emo Capitals's website does not constitute a
part of this release.
SOURCE Emo Capital
For further information:
Phone: (888) 374-2961